Meeting of the Horizontal Working Party on Drugs Date: 5 and 6 May 2014 Time: 10.00, 10.00 Venue: COUNCIL JUSTUS LIPSIUS BUILDING Rue de la Loi 175, 1048 BRUSSELS (22898/EU XXV.GP)

RAT: CM 2518/14 PUBLIC
25.04.2014
englisch

EU-V: Tagesordnung

Meeting of the Horizontal Working Party on Drugs Date: 5 and 6 May 2014 Time: 10.00, 10.00 Venue: COUNCIL JUSTUS LIPSIUS BUILDING Rue de la Loi 175, 1048 BRUSSELS

Gruppe: Horizontale Gruppe "Drogen" (HDG)

betrifft Sitzungen am 05.05.2014 und 06.05.2014

Erstellt am 25.04.2014 von: Justizielle Zusammenarbeit in Zivil- und Strafsachen sowie polizeiliche und zollbehördliche Zusammenarbeit

Eingelangt am 25.04.2014, U32 Übermittlung

 Aufklappen
Linkart Link
RAT
CM 2457/14
RAT
CM 2491/14
RAT
CM 2521/14
RAT
DS 1201/14
RAT
1046/3/14
RAT
14387/1/12
RAT
2522/14
RAT
8960/14
RAT
8961/14
RAT
8962/14
RAT
8963/14
RMA
CORDROGUE 20
RMA
CORDROGUE 21
RMA
CORDROGUE 22
RMA
CORDROGUE 23
RMA
SAN 174
RMA
SAN 175
RMA
SAN 176
RMA
SAN 177
RAG
Dublin - Gruppe
RAG
Horizontale Gruppe "Drogen" (HDG)
 Aufklappen
Datum Dok.Nr.
Art Betreff
25.04.2014 RAT: 8961/14 EUST
Risk Assessment Report on the new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide) (22891/EU XXV.GP)
25.04.2014 RAT: 8960/14 EUST
Risk Assessment Report on the new psychoactive substance 25I-NBOMe (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine) (22894/EU XXV.GP)
25.04.2014 RAT: 8962/14 EUST
Risk Assessment Report on the new psychoactive substance MDPV (3,4-methylenedioxypyrovalerone) (22896/EU XXV.GP)
25.04.2014 RAT: 8963/14 EUST
Risk Assessment Report on the new psychoactive substance methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone) (22906/EU XXV.GP)
02.05.2014 RAT: CM 2521/14 EUTO
Technical Committee of the EU/CELAC Mechanism on Drugs Date: 6 May 2014 Time: 15.00 Venue: COUNCIL LEX BUILDING Rue de la Loi 145, 1048 BRUSSELS (23773/EU XXV.GP)
15.05.2014 RAT: 9893/14 EUST
Summary of discussions (25648/EU XXV.GP)
04.06.2014 RAT: 10329/14 EUST
Summary of discussions (28018/EU XXV.GP)
 Aufklappen
Dok.Nr.
Betreff
RAT: 8960/14 Risk Assessment Report on the new psychoactive substance 25I-NBOMe (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine) (22894/EU XXV.GP)
RAT: 8961/14 Risk Assessment Report on the new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide) (22891/EU XXV.GP)
RAT: 8962/14 Risk Assessment Report on the new psychoactive substance MDPV (3,4-methylenedioxypyrovalerone) (22896/EU XXV.GP)
RAT: 8963/14 Risk Assessment Report on the new psychoactive substance methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone) (22906/EU XXV.GP)
RAT: CM 2521/14 Technical Committee of the EU/CELAC Mechanism on Drugs Date: 6 May 2014 Time: 15.00 Venue: COUNCIL LEX BUILDING Rue de la Loi 145, 1048 BRUSSELS (23773/EU XXV.GP)
RAT: CM 2522/14 Meeting of the Dublin Group Date: 7 May 2014 Time: 10.00 Venue: COUNCIL JUSTUS LIPSIUS BUILDING Rue de la Loi 175, 1048 BRUSSELS (23643/EU XXV.GP)
RAT: CM 2491/14 EU-USA dialogue on drugs Date: 8 May 2014 Time: 10.00 Venue: COUNCIL JUSTUS LIPSIUS BUILDING Rue de la Loi 175, 1048 BRUSSELS (21854/EU XXV.GP)
RAT: CM 2457/14 EU-Western Balkans dialogue on drugs Date: 8 May 2014 Time: 15.00 Venue: COUNCIL JUSTUS LIPSIUS BUILDING Rue de la Loi 175, 1048 BRUSSELS (21604/EU XXV.GP)
RAT: 1046/14
 Aufklappen
 Aufklappen
Thema
Gesundheitswesen
Institutionelle Fragen
Justiz und Inneres